Stay updated on Nivolumab+Radiation±Ipilimumab in NSCLC Brain Metastases Clinical Trial

Sign up to get notified when there's something new on the Nivolumab+Radiation±Ipilimumab in NSCLC Brain Metastases Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab+Radiation±Ipilimumab in NSCLC Brain Metastases Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The page displays a new revision label, updating from Revision: v3.5.4 to Revision: v3.5.5, signaling an administrative update to the study record.
    Difference
    0.0%
    Check dated 2026-06-05T10:58:39.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    14 days ago
    Change Detected
    Summary
    The study record's update dates were refreshed to 2026 dates (e.g., 2026-05-20 and 2026-05-18), with older 2025 timestamps removed, indicating ongoing maintenance of the record.
    Difference
    0.2%
    Check dated 2026-05-22T09:28:55.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    A new revision tag was introduced: Revision: v3.5.4, replacing Revision: v3.5.3. This signals a minor update to the page release and does not modify the study content or data shown on the record.
    Difference
    0.0%
    Check dated 2026-05-15T05:10:45.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.3, indicating a new release/version. This update does not modify the study data or visible content.
    Difference
    0.0%
    Check dated 2026-04-30T18:01:54.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Difference
    0.0%
    Check dated 2026-04-16T11:50:48.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Added site revision: Revision: v3.5.0. Deleted site revision: Revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-18T21:48:05.000Z thumbnail image

Stay in the know with updates to Nivolumab+Radiation±Ipilimumab in NSCLC Brain Metastases Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab+Radiation±Ipilimumab in NSCLC Brain Metastases Clinical Trial page.